Header Logo

Connection

WEN-JEN HWU to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications WEN-JEN HWU has written about Xenograft Model Antitumor Assays.
WEN-JEN HWU
Connection Strength
0.021
Xenograft Model Antitumor Assays
  1. Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight. 2018 02 22; 3(4).
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.